IL37
Basic information
Region (hg38): 2:112911165-112918882
Previous symbols: [ "IL1F7" ]
Links
Phenotypes
GenCC
Source:
- inflammatory bowel disease (infantile ulcerative colitis) 31, autosomal recessive (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Inflammatory bowel disease (infantile ulcerative colitis) 31, autosomal recessive | AR | Allergy/Immunology/Infectious; Gastrointestinal | The condition can manifest with inflammatory bowel disease, and medical management (eg, with mesalamine, corticosteroids, and azathioprine) have been described as being beneficial | Allergy/Immunology/Infectious; Gastrointestinal | 33674380 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL37 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 10 | 13 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 11 | 3 | 2 |
Variants in IL37
This is a list of pathogenic ClinVar variants found in the IL37 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-112913015-G-A | Inflammatory bowel disease (infantile ulcerative colitis) 31, autosomal recessive | Uncertain significance (Mar 26, 2024) | ||
2-112913047-T-C | not specified | Uncertain significance (Jun 04, 2024) | ||
2-112913816-C-A | not specified | Uncertain significance (Sep 22, 2022) | ||
2-112913833-A-G | Benign (Feb 18, 2020) | |||
2-112913842-T-A | Uncertain significance (Dec 01, 2022) | |||
2-112917137-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
2-112917153-C-G | not specified | Uncertain significance (Feb 02, 2022) | ||
2-112917153-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
2-112917165-G-T | not specified | Uncertain significance (Sep 27, 2022) | ||
2-112917179-G-T | not specified | Uncertain significance (Feb 06, 2024) | ||
2-112917184-C-G | not specified | Likely benign (Jan 17, 2024) | ||
2-112917200-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
2-112917210-A-G | not specified | Uncertain significance (Jan 10, 2022) | ||
2-112917242-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
2-112917258-A-C | Likely benign (Jan 08, 2018) | |||
2-112917671-C-A | not specified | Uncertain significance (Oct 17, 2023) | ||
2-112917677-C-T | not specified | Conflicting classifications of pathogenicity (Feb 01, 2023) | ||
2-112917681-G-A | Likely benign (Mar 01, 2022) | |||
2-112917695-T-C | not specified | Uncertain significance (Apr 23, 2024) | ||
2-112918606-C-T | Benign (Jul 04, 2018) | |||
2-112918682-T-C | Inflammatory bowel disease | Pathogenic (Jun 23, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL37 | protein_coding | protein_coding | ENST00000263326 | 5 | 5912 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000123 | 0.405 | 125728 | 0 | 8 | 125736 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0421 | 119 | 118 | 1.01 | 0.00000593 | 1438 |
Missense in Polyphen | 26 | 24.045 | 1.0813 | 347 | ||
Synonymous | -0.679 | 53 | 47.1 | 1.13 | 0.00000268 | 402 |
Loss of Function | 0.131 | 6 | 6.36 | 0.944 | 2.65e-7 | 91 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000145 | 0.000145 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Suppressor of innate inflammatory and immune responses involved in curbing excessive inflammation. This function requires SMAD3. Suppresses, or reduces, proinflammatory cytokine production, including IL1A and IL6, as well as CCL12, CSF1, CSF2, CXCL13, IL1B, IL23A and IL1RN, but spares anti-inflammatory cytokines. Inhibits dendritic cell activation. {ECO:0000269|PubMed:18390730, ECO:0000269|PubMed:20935647}.;
- Pathway
- Signaling by Interleukins;Cytokine Signaling in Immune system;Interleukin-18 signaling;Immune System;Interleukin-37 signaling;Interleukin-1 family signaling
(Consensus)
Recessive Scores
- pRec
- 0.0767
Intolerance Scores
- loftool
- rvis_EVS
- 1.62
- rvis_percentile_EVS
- 95.96
Haploinsufficiency Scores
- pHI
- 0.0382
- hipred
- N
- hipred_score
- 0.317
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- inflammatory response;immune response;regulation of signaling receptor activity;cytokine-mediated signaling pathway;neutrophil chemotaxis;positive regulation of interleukin-6 production;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of JNK cascade;cellular response to lipopolysaccharide;cellular response to cytokine stimulus
- Cellular component
- extracellular region;extracellular space;nucleoplasm;cytosol;intracellular membrane-bounded organelle
- Molecular function
- cytokine activity;interleukin-1 receptor binding